SE505274C2 - Användning av en hydrofob zeolit för avlägsnande av för injektionslösningar i läkemedelssammanhang använda konserveringsmedel från en proteinlösning - Google Patents

Användning av en hydrofob zeolit för avlägsnande av för injektionslösningar i läkemedelssammanhang använda konserveringsmedel från en proteinlösning

Info

Publication number
SE505274C2
SE505274C2 SE9503731A SE9503731A SE505274C2 SE 505274 C2 SE505274 C2 SE 505274C2 SE 9503731 A SE9503731 A SE 9503731A SE 9503731 A SE9503731 A SE 9503731A SE 505274 C2 SE505274 C2 SE 505274C2
Authority
SE
Sweden
Prior art keywords
zeolite
solution
use according
syringe
hydrophobic
Prior art date
Application number
SE9503731A
Other languages
English (en)
Swedish (sv)
Other versions
SE9503731D0 (sv
SE9503731L (sv
Inventor
Sten Andersson
Haakan Eriksson
Kaare Larsson
Original Assignee
Sten Andersson
Haakan Eriksson
Larsson Kare
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sten Andersson, Haakan Eriksson, Larsson Kare filed Critical Sten Andersson
Priority to SE9503731A priority Critical patent/SE505274C2/sv
Publication of SE9503731D0 publication Critical patent/SE9503731D0/xx
Priority to AT96935707T priority patent/ATE222802T1/de
Priority to JP9516525A priority patent/JPH11514920A/ja
Priority to DE69623354T priority patent/DE69623354T2/de
Priority to CA002235767A priority patent/CA2235767A1/en
Priority to AU73524/96A priority patent/AU693047B2/en
Priority to EP96935707A priority patent/EP0956155B1/en
Priority to PCT/SE1996/001306 priority patent/WO1997015391A1/en
Priority to US09/051,752 priority patent/US5936061A/en
Publication of SE9503731L publication Critical patent/SE9503731L/xx
Publication of SE505274C2 publication Critical patent/SE505274C2/sv

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/02Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material
    • B01J20/10Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising inorganic material comprising silica or silicate
    • B01J20/16Alumino-silicates
    • B01J20/18Synthetic zeolitic molecular sieves
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/34Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/61Growth hormone [GH], i.e. somatotropin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2220/00Aspects relating to sorbent materials
    • B01J2220/50Aspects relating to the use of sorbent or filter aid materials
    • B01J2220/64In a syringe, pipette, e.g. tip or in a tube, e.g. test-tube or u-shape tube

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Water Supply & Treatment (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
SE9503731A 1995-10-24 1995-10-24 Användning av en hydrofob zeolit för avlägsnande av för injektionslösningar i läkemedelssammanhang använda konserveringsmedel från en proteinlösning SE505274C2 (sv)

Priority Applications (9)

Application Number Priority Date Filing Date Title
SE9503731A SE505274C2 (sv) 1995-10-24 1995-10-24 Användning av en hydrofob zeolit för avlägsnande av för injektionslösningar i läkemedelssammanhang använda konserveringsmedel från en proteinlösning
US09/051,752 US5936061A (en) 1995-10-24 1996-10-15 Use of hydrophobic zeolites, syringe and method for removing of preservatives from a polypeptide solution
CA002235767A CA2235767A1 (en) 1995-10-24 1996-10-15 Use of hydrophobic zeolites, syringe and method for removing of preservatives from a polypeptide solution
JP9516525A JPH11514920A (ja) 1995-10-24 1996-10-15 ポリペプチド溶液から防腐剤を除去するための疎水性ゼオライトの使用、シリンジおよび方法
DE69623354T DE69623354T2 (de) 1995-10-24 1996-10-15 Verwendung von hydrophoben zeolithen, sprize und methode zur entfernung von konservierungsmitteln aus einer polypeptidlösung
AT96935707T ATE222802T1 (de) 1995-10-24 1996-10-15 Verwendung von hydrophoben zeolithen, sprize und methode zur entfernung von konservierungsmitteln aus einer polypeptidlösung
AU73524/96A AU693047B2 (en) 1995-10-24 1996-10-15 Use of hydrophobic zeolites, syringe and method for removing of preservatives from a polypeptide solution
EP96935707A EP0956155B1 (en) 1995-10-24 1996-10-15 Use of hydrophobic zeolites, syringe and method for removing of preservatives from a polypeptide solution
PCT/SE1996/001306 WO1997015391A1 (en) 1995-10-24 1996-10-15 Use of hydrophobic zeolites, syringe and method for removing of preservatives from a polypeptide solution

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9503731A SE505274C2 (sv) 1995-10-24 1995-10-24 Användning av en hydrofob zeolit för avlägsnande av för injektionslösningar i läkemedelssammanhang använda konserveringsmedel från en proteinlösning

Publications (3)

Publication Number Publication Date
SE9503731D0 SE9503731D0 (sv) 1995-10-24
SE9503731L SE9503731L (sv) 1997-04-25
SE505274C2 true SE505274C2 (sv) 1997-07-28

Family

ID=20399935

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9503731A SE505274C2 (sv) 1995-10-24 1995-10-24 Användning av en hydrofob zeolit för avlägsnande av för injektionslösningar i läkemedelssammanhang använda konserveringsmedel från en proteinlösning

Country Status (9)

Country Link
US (1) US5936061A (ja)
EP (1) EP0956155B1 (ja)
JP (1) JPH11514920A (ja)
AT (1) ATE222802T1 (ja)
AU (1) AU693047B2 (ja)
CA (1) CA2235767A1 (ja)
DE (1) DE69623354T2 (ja)
SE (1) SE505274C2 (ja)
WO (1) WO1997015391A1 (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000037364A1 (en) * 1998-12-09 2000-06-29 Ordio Ab Purification of water

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802140D0 (sv) * 1998-06-16 1998-06-16 Ordio Ab Zeoliter för adsorption
US6589224B2 (en) * 2001-02-14 2003-07-08 Renal Tech International Llc Method of introducing fluids into a patient's body
US20050031708A1 (en) * 2003-08-06 2005-02-10 Portney Micah S. Composition comprising a zeolite compound for treatment of diseases
US20090111751A1 (en) * 2006-02-24 2009-04-30 Novo Nordisk Health Care Ag Method of Removing a Non-Metallic Protein Inhibitor From a Liquid Pharmaceutical Preparation
CA2574746A1 (en) * 2007-01-22 2008-07-22 Duoject Medical Systems Inc. Syringe having venting structure and method for mixing two substances in a syringe
WO2009027478A2 (en) * 2007-08-29 2009-03-05 Novo Nordisk Health Care Ag A method of removing preservatives from a liquid pharmaceutical preparation
US10130288B2 (en) 2013-03-14 2018-11-20 Cell and Molecular Tissue Engineering, LLC Coated sensors, and corresponding systems and methods
US10405961B2 (en) 2013-03-14 2019-09-10 Cell and Molecular Tissue Engineering, LLC Coated surgical mesh, and corresponding systems and methods
EP3179975A4 (en) * 2014-08-13 2018-04-18 University of Florida Research Foundation, Inc. Preservative removal from eye drops
WO2016196516A1 (en) 2015-06-03 2016-12-08 William Kenneth Ward Measurement of glucose in an insulin delivery catheter by minimizing the adverse effects of insulin preservatives
CN109069740B (zh) * 2016-04-22 2021-10-29 伊莱利利公司 用于减少胰岛素中的间甲酚浓度的具有包含聚合吸着剂的组件的输注组
EP3618890A1 (en) 2017-05-01 2020-03-11 Becton, Dickinson and Company Filter for reducing phenolic compounds from insulin and related infusion and injection devices
MX2019014615A (es) 2017-06-08 2020-02-07 Amgen Inc Dispositivo de administracion de farmacos accionado por par de torsion.
JP7517996B2 (ja) * 2018-04-27 2024-07-17 ベクトン・ディキンソン・アンド・カンパニー 送達デバイスおよび吸着剤
WO2019236653A1 (en) * 2018-06-06 2019-12-12 Entopsis Llc System and method for removing phenolic preservations from insulin formulations
CN115397374A (zh) 2019-12-19 2022-11-25 特清公司 从滴眼剂中去除防腐剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4240986A (en) * 1979-02-23 1980-12-23 Uop Inc. Process for the separation of ortho-chloronitrobenzene
EP0021267B1 (en) * 1979-06-18 1982-06-16 PQ Corporation Agglomerated zeolite ion exchanger
SE8902919L (sv) * 1989-09-05 1991-03-05 Haakan Eriksson Anvaendning av zeoliter som adsorbenter av detergenter i biokemiska/biotekniska system och processer
SE9201976D0 (sv) * 1992-06-26 1992-06-26 Tektolit Ab Haakan Eriksson En metod foer att adsorbera proteiner och peptider till hydrofoba zeoliter
US5314855A (en) * 1992-11-09 1994-05-24 Akzo N.V. Adsorbent compositions and methods of manufacture
US5585007A (en) * 1994-12-07 1996-12-17 Plasmaseal Corporation Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000037364A1 (en) * 1998-12-09 2000-06-29 Ordio Ab Purification of water

Also Published As

Publication number Publication date
CA2235767A1 (en) 1997-05-01
DE69623354D1 (de) 2002-10-02
WO1997015391A1 (en) 1997-05-01
JPH11514920A (ja) 1999-12-21
EP0956155B1 (en) 2002-08-28
EP0956155A1 (en) 1999-11-17
DE69623354T2 (de) 2003-01-09
AU7352496A (en) 1997-05-15
US5936061A (en) 1999-08-10
ATE222802T1 (de) 2002-09-15
SE9503731D0 (sv) 1995-10-24
AU693047B2 (en) 1998-06-18
SE9503731L (sv) 1997-04-25

Similar Documents

Publication Publication Date Title
SE505274C2 (sv) Användning av en hydrofob zeolit för avlägsnande av för injektionslösningar i läkemedelssammanhang använda konserveringsmedel från en proteinlösning
AU621148B2 (en) Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography
DE69027187T2 (de) Verfahren zur inaktivierung von viren in mit viren verunreinigten pharmazeutischen zusammensetzungen
EP2249862B1 (en) Method for producing a clottable concentrate of platelet growth factors
AU698154B2 (en) System for viral inactivation of blood
JP2000513377A (ja) プリオンのクロマトグラフィー除去方法
AU7650394A (en) Displacement chromatography process and purified hemoglobin product
Rock et al. Distribution of di (2-ethylhexyl) phthalate and products in blood and blood components.
EP2389942A1 (en) Virally-inactivated growth factors-containing platelet lysate depleted of PDGF and VEGF and preparation method thereof
GB1597204A (en) Process of preparing a serum protein composition for intravenous application
RU2719468C2 (ru) Способы очистки и/или вирусной инактивации
SK54993A3 (en) Imidoester cross-linked hemoglobin compositions
EP1597271B1 (de) Peptide gegen kälteunverträglichkeit hervorrufende autoantikörper und ihre verwendung
JPS59231097A (ja) 均質ヒト免疫インターフェロンサブタイプ21kおよびその製造法
Ramanathan et al. Antiviral principles of propionibacteria-isolation and activity of propionins B and C
CN100569287C (zh) 犬静脉注射免疫球蛋白、其制备方法以及犬静脉注射免疫球蛋白制剂
EP1684868B1 (de) Bekämpfung von hi-virus infektionen mit durch hypochlorige säure oxidiertem menschlichem blutplasma
EP1048307B1 (en) Dialysis membrane for the preparation of hematopoietic inhibiting factor containing compositions
RU2140287C1 (ru) Способ получения альбумина
CA1303295C (en) Immunosuppressor and method of extraction thereof
Gebauer et al. Ion-exchange chromatography separation of the detergent and the solvent from immunoglobulins after solvent–detergent treatment
Galloway Hepatitis A viral safety of plasma-derived factor VIII concentrate koate®-HP
TW201319084A (zh) 血小板源腦源性神經滋養因子濃厚液及其製備方法
Solutions et al. Aluminium in Human
DE10311106A1 (de) Peptide gegen Kälteunverträglichkeit hervorrufende Autoantikörper und ihre Verwendung

Legal Events

Date Code Title Description
NUG Patent has lapsed